Weight Change Pattern and Survival Outcome of Women with Endometrial Cancer
- PMID: 27112587
- PMCID: PMC7523388
- DOI: 10.1245/s10434-016-5237-9
Weight Change Pattern and Survival Outcome of Women with Endometrial Cancer
Abstract
Objective: The aim of this study was to determine the association between weight change patterns and survival outcomes of women with endometrial cancer.
Methods: This retrospective study examined surgically-staged endometrial cancer cases with available weight information between 1999 and 2013 (n = 665). Proportional body mass index (delta-BMI) change at 6 months, 1 and 2 years after hysterectomy was compared with baseline BMI and correlated to patient demographics, tumor characteristics, treatment type, and disease-free survival (DFS) and overall survival (OS).
Results: Mean BMI was 35.6, and 69 % of cases were obese. At 6 months, 1 and 2 years after surgery, 39.1, 51.6, and 57.0 % of the study population, respectively, gained weight compared with pre-treatment baseline. In univariate analysis, 6-month delta-BMI change was significantly associated with DFS and OS, demonstrating bidirectional effects (both p < 0.001): 5-year rates, ≥15.0 % delta-BMI loss (33.5 and 59.1 %), 7.5-14.9 % loss (67.3 and 70.0 %), <7.5 % loss (87.8 and 95.7 %), <7.5 % gain (87.2 and 90.3 %), 7.5-14.9 % gain (64.6 and 67.6 %), and ≥15.0 % gain (32.5 and 66.7 %). In multivariable analysis controlling for age, ethnicity, baseline BMI, histology, grade, stage, chemotherapy, and radiotherapy, 6-month delta-BMI change remained an independent prognostic factor for DFS and OS (all p < 0.05): adjusted hazard ratios, ≥15 % delta-BMI loss (3.35 and 5.39), 7.5-14.9 % loss (2.35 and 4.19), 7.5-14.9 % gain (2.58 and 3.33), and ≥15.0 % gain (2.50 and 3.45) compared with <7.5 % loss. Similar findings were observed at a 1-year time point (p < 0.05). Baseline BMI was not associated with survival outcome (p > 0.05).
Conclusion: Our results demonstrated that endometrial cancer patients continued to gain weight after hysterectomy, and post-treatment weight change had bidirectional effects on survival outcome.
Conflict of interest statement
Figures
Similar articles
-
Influence of body mass index on clinicopathologic features, surgical morbidity and outcome in patients with endometrial cancer.Arch Gynecol Obstet. 2012 Nov;286(5):1269-76. doi: 10.1007/s00404-012-2431-2. Epub 2012 Jun 24. Arch Gynecol Obstet. 2012. PMID: 22729137
-
Association of Low-Dose Aspirin and Survival of Women With Endometrial Cancer.Obstet Gynecol. 2016 Jul;128(1):127-137. doi: 10.1097/AOG.0000000000001491. Obstet Gynecol. 2016. PMID: 27275802 Free PMC article.
-
Combination of adjuvant chemotherapy and radiotherapy is associated with improved survival at early stage type II endometrial cancer and carcinosarcoma.Aust N Z J Obstet Gynaecol. 2016 Apr;56(2):199-206. doi: 10.1111/ajo.12449. Epub 2016 Feb 18. Aust N Z J Obstet Gynaecol. 2016. PMID: 26890292
-
Pelvic lymph node count is an important prognostic variable for FIGO stage I and II endometrial carcinoma with high-risk histology.Gynecol Oncol. 2006 Jul;102(1):92-7. doi: 10.1016/j.ygyno.2005.11.032. Epub 2006 Jan 10. Gynecol Oncol. 2006. PMID: 16406063
-
Improved survival with adjuvant brachytherapy in stage IA endometrial cancer of unfavorable histology.Gynecol Oncol. 2018 Oct;151(1):82-90. doi: 10.1016/j.ygyno.2018.08.028. Epub 2018 Aug 28. Gynecol Oncol. 2018. PMID: 30170976
Cited by
-
Body mass index, weight change, and cancer prognosis: a meta-analysis and systematic review of 73 cohort studies.ESMO Open. 2024 Mar;9(3):102241. doi: 10.1016/j.esmoop.2024.102241. Epub 2024 Mar 4. ESMO Open. 2024. PMID: 38442453 Free PMC article.
-
Impact of weight loss after treatment on survival outcomes of overweight and obese patients with early‑stage endometrial cancer.Oncol Lett. 2023 Dec 5;27(2):44. doi: 10.3892/ol.2023.14177. eCollection 2024 Feb. Oncol Lett. 2023. PMID: 38106524 Free PMC article.
-
Abdominal fat distribution in endometrial cancer: from diagnosis to follow-up.BMC Cancer. 2025 May 15;25(1):879. doi: 10.1186/s12885-025-14155-3. BMC Cancer. 2025. PMID: 40375215 Free PMC article.
-
Interventions for weight reduction in obesity to improve survival in women with endometrial cancer.Cochrane Database Syst Rev. 2023 Mar 27;3(3):CD012513. doi: 10.1002/14651858.CD012513.pub3. Cochrane Database Syst Rev. 2023. PMID: 36971688 Free PMC article.
-
Higher baseline BMI and lower estimated median income associated with increasing BMI after endometrial cancer diagnosis.Gynecol Oncol Rep. 2022 Dec 13;44:101123. doi: 10.1016/j.gore.2022.101123. eCollection 2022 Dec. Gynecol Oncol Rep. 2022. PMID: 36589506 Free PMC article.
References
-
- Siegel RL, Miller KD, Jemal A. Cancer statistics, 2015. CA Cancer J Clin. 2015;65:5–29. - PubMed
-
- Fader AN, Arriba LN, Frasure HE, von Gruenigen VE. Endometrial cancer and obesity: epidemiology, biomarkers, prevention and survivorship. Gynecol Oncol. 2009;114:121–27. - PubMed
-
- Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med. 2003;348:1625–38. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical